SPDEF and neoplasm: Finally, the one member only of class IV, Spdef, which binds a 5′-GGAT-3′ core [4], is known on the one hand to be involved in tumour progression and endocrine resistance in breast cancers [43], and on the other hand to act as a putative tumour suppressor in prostate and colorectal carcinomas [44,45].